OKYO Pharma Limited Adjustments For Unrealised Foreign Exchange Losses Gains
OKYO Pharma Limited (OKYO) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -$96.98 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2025-07-18
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2025-03-31 | -$96.98K 20-F · filed 2025-07-18 |
| 2024-03-31 | $55.18K 20-F · filed 2025-07-18 |
| 2023-03-31 | $51.19K 20-F · filed 2025-07-18 |
| 2022-03-31 | -$9.23K 20-F · filed 2024-08-13 |
| 2021-03-31 | $4.06K 20-F · filed 2023-08-15 |
| 2020-03-31 | $13.91K 20-F · filed 2022-08-15 |